Literature DB >> 8816929

Cleavage and release of a soluble form of the receptor tyrosine kinase ARK in vitro and in vivo.

M Costa1, P Bellosta, C Basilico.   

Abstract

The receptor tyrosine kinase ARK (also called AXL or UFO) is the murine prototype of a small family of receptors with an extracellular domain resembling cell adhesion molecules and a conserved tyrosine kinase domain. ARK is capable of homophilic binding, as well as of binding of GAS6, a secreted member of the class of vitamin K dependent proteins whose expression is up-regulated in growth-arrested cells. To gain understanding of the physiological role of ARK signaling, we have investigated the ARK forms which are expressed by cells in culture as well as by mouse organs. We found that ARK is not only expressed as a transmembrane protein, but is also cleaved in the extracellular domain to generate a soluble ARK form of about 65 kDa, which is easily detected in conditioned media of ARK expressing cells, in serum and plasma and in mouse organs. Soluble ARK is also produced by tumor cells in vivo. The function of these molecules could be that of binding GAS6, thereby inhibiting the interaction of this ligand with its cell-associated receptor, or they could be involved in binding to ARK itself.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816929     DOI: 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO;2-U

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Lutz Thon; Uwe Mamat; Paola Bellosta; Claudio Basilico; Dieter Adam; Ralf Paus; Silvia Bulfone-Paus
Journal:  EMBO J       Date:  2005-11-24       Impact factor: 11.598

Review 2.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

3.  A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.

Authors:  Susan Sather; Karla D Kenyon; Jerry B Lefkowitz; Xiayuan Liang; Brian C Varnum; Peter M Henson; Douglas K Graham
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

4.  Shedding of the Mer tyrosine kinase receptor is mediated by ADAM17 protein through a pathway involving reactive oxygen species, protein kinase Cδ, and p38 mitogen-activated protein kinase (MAPK).

Authors:  Edward Thorp; Tomas Vaisar; Manikandan Subramanian; Lauren Mautner; Carl Blobel; Ira Tabas
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

5.  Cleavage of Mer tyrosine kinase (MerTK) from the cell surface contributes to the regulation of retinal phagocytosis.

Authors:  Ah-Lai Law; Célia Parinot; Jonathan Chatagnon; Basile Gravez; José-Alain Sahel; Shomi S Bhattacharya; Emeline F Nandrot
Journal:  J Biol Chem       Date:  2014-12-23       Impact factor: 5.157

6.  Hypothalamic but not pituitary or ovarian defects underlie the reproductive abnormalities in Axl/Tyro3 null mice.

Authors:  Angela Pierce; Mei Xu; Brian Bliesner; Zhilin Liu; JoAnne Richards; Stuart Tobet; Margaret E Wierman
Journal:  Mol Cell Endocrinol       Date:  2011-04-22       Impact factor: 4.102

7.  Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.

Authors:  Vadim Budagian; Elena Bulanova; Zane Orinska; Erwin Duitman; Katja Brandt; Andreas Ludwig; Dieter Hartmann; Greg Lemke; Paul Saftig; Silvia Bulfone-Paus
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

Review 8.  TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.

Authors:  Rachel M A Linger; Amy K Keating; H Shelton Earp; Douglas K Graham
Journal:  Adv Cancer Res       Date:  2008       Impact factor: 6.242

9.  Functional consequences of AXL sequence variants in hypogonadotropic hypogonadism.

Authors:  S Salian-Mehta; M Xu; A J Knox; L Plummer; D Slavov; M Taylor; S Bevers; R S Hodges; W F Crowley; M E Wierman
Journal:  J Clin Endocrinol Metab       Date:  2014-01-29       Impact factor: 5.958

10.  Recombinant Gas6 augments Axl and facilitates immune restoration in an intracerebral hemorrhage mouse model.

Authors:  Lu-Sha Tong; An-Wen Shao; Yi-Bo Ou; Zhen-Ni Guo; Anatol Manaenko; Brandon J Dixon; Jiping Tang; Min Lou; John H Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.